Skip to content

Elastofibroma Dorsi: Clinical Features, Surgical Outcomes, and Risk Factors

Clinical Characteristics of Elastofibroma Dorsi, Long-Term Outcomes After Surgical Resection, and Analysis of Risk Factors

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07010224
Enrollment
102
Registered
2025-06-08
Start date
2010-01-01
Completion date
2025-12-01
Last updated
2026-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elastofibroma Dorsi

Keywords

Elastofibroma Dorsi, Subscapular Mass, Chest Wall Tumor, Risk Factors, Thoracic Surgery

Brief summary

This study aims to retrospectively evaluate patients who underwent surgical treatment for elastofibroma dorsi, a rare benign tumor typically located in the subscapular region of the chest wall. The study will analyze demographic and clinical features, risk factors, diagnostic imaging methods, postoperative complications, and recurrence rates. By identifying potential predictors of complications and recurrence, the study hopes to contribute to the understanding and management of this silent and often incidental lesion.

Interventions

Review of archived medical, surgical, and radiological records of patients diagnosed with elastofibroma dorsi and treated surgically. No active intervention was administered as part of the study.

Sponsors

Ondokuz Mayıs University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who underwent surgical treatment for elastofibroma dorsi * Histopathological confirmation of the diagnosis * Minimum of 1-month postoperative follow-up available * Age 18 years or older * Accessible medical and imaging records in hospital archives * Signed informed consent available in patient records (if applicable)

Exclusion criteria

* Patients diagnosed with elastofibroma dorsi but not treated surgically * Cases without histopathological confirmation * Incomplete or insufficient medical and radiological records * Postoperative follow-up period less than 1 month * Patients younger than 18 years * Absence of documented informed consent (if applicable)

Design outcomes

Primary

MeasureTime frameDescription
Completion of Retrospective Data Collection FormWithin 3 months after data collection beginsCompletion of data collection from medical records of patients diagnosed with elastofibroma dorsi who underwent surgical treatment, including demographic features, clinical presentation, imaging modalities, surgical outcomes, postoperative complications, and recurrence.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 25, 2026